Page 32 - 《中国药房》2026年5期

某市紧密型县域医共体集中（云）审方中心建设现状及发展建议
Δ

1 #
1＊
何 璐 ，朱鸣阳 ，胡晓蕾 ，钱 妍 （1.重庆医科大学附属第二医院药学部，重庆 400010；2.重庆大学附属沙
2
1
坪坝医院药学部，重庆 401300）
中图分类号 R-1；R952 文献标志码 A 文章编号 1001-0408（2026）05-0578-06
DOI 10.6039/j.issn.1001-0408.2026.05.05

摘 要 目的 调研某市已建成和筹建中的紧密型县域医共体集中（云）审方中心（简称“审方中心”）实际建设和运行情况，为提高
审方中心建设质量提供参考。方法 采用线上问卷收集某市51家已建成和筹建中的审方中心的基本情况、经费来源、人才管理、
制度建设、审方规则维护、处方审核、处方点评和审方中心数据利用情况以及当前面临的困难，并进行数据汇总分析。结果 共计
回收有效问卷51份，包括32家已建成和19家筹建中的审方中心。在已建成的32家审方中心中，建设经费来源途径为财政经费拨
款的占比最高，为56.25%；仅25.00%的审方中心药师的资质完全符合国家规范要求；审方规则月均维护条目数大于10条的审方
中心的占比仅为 55.00%；处方审核工作对门诊处方实现了全覆盖，但有 37.50% 的审方中心仅能支持单张处方合理性审核，
50.00%的审方中心尚不支持调阅检验检查结果辅助审方；有40.62%的审方中心尚未常规开展对基层医疗机构的处方点评；审方
中心数据主要用于用药监测。在筹建中的19家审方中心中，有63.16%都没有经费来源。结论 该市审方中心在运行和建设过程
中，普遍存在经费短缺、协同激励机制缺乏和人手不足等问题。建议国家尽快出台审方中心建设的统一标准，各地卫生健康行政
部门结合区域实际制定配套政策，明确考核指标。
关键词 紧密型县域医共体；集中审方；云审方；审方中心；运行成本；绩效管理

Research on the current situation and development suggestions of centralized （cloud） prescription review
center of the close-knit county-level medical consortium in a city
HE Lu ，ZHU Mingyang ，HU Xiaolei ，QIAN Yan（1. Dept. of Pharmacy， the Second Affiliated Hospital of
2
1
1
1
Chongqing Medical University， Chongqing 400010， China；2. Dept. of Pharmacy， Shapingba Hospital，
Chongqing University， Chongqing 401300， China）
ABSTRACT OBJECTIVE To investigate the actual construction and operation status of established and under-construction
centralized （cloud） prescription review centers （shortened for “prescription review center”） of close-knit county-level medical
consortium in a certain city， so as to provide reference for improving the construction quality of the prescription review center.
METHODS An online questionnaire survey was conducted to collect the data from 51 established and under-construction
prescription review center in the city， covering basic information， funding sources， talent management， system construction，
review rule maintenance， prescription review practices， prescription evaluation， data utilization， and current challenges. The
collected data were summarized and analyzed. RESULTS A total of 51 valid questionnaires were retrieved， covering 32 established
and 19 under-construction prescription review center. Among the 32 established prescription review centers， the main funding
sources for their construction came from government financial allocations， accounting for 56.25%. Only 25.00% of prescription
review center had review pharmacists who fully met national qualification requirements， and just 55.00% updated more than 10
review rule entries per month on average. Outpatient prescription verification realized full coverage， but 37.50% of prescription
review centers only supported rationality verification of single prescriptions， and 50.00% could not retrieve laboratory and
examination results to assist in prescription review. Additionally， 40.62% of prescription review center had not regularly conducted
prescription evaluations for primary care institutions. The data from prescription review center was mainly used to support
medication monitoring. Among the 19 prescription review centers currently in the planning stage， 63.16% had no identified funding
sources. CONCLUSIONS The operation and construction of
Δ 基金项目 国家临床重点专科建设项目（No.渝卫办发〔2023〕48 prescription review center in the city face challenges， such as
号）；重庆市临床药学重点专科建设项目（No.渝卫办发〔2023〕2号） funding shortages， absence of collaborative incentive
＊第一作者 主管药师，硕士。研究方向：临床药学。E-mail：
mechanisms， and insufficient manpower.It is suggested that the
317248849@qq.com
# 通信作者 主任药师，硕士生导师。研究方向：临床药学。 state should issue a unified standard for the construction of the
E-mail：552590989@qq.com prescription review center as soon as possible， and local health

· 578 · China Pharmacy 2026 Vol. 37 No. 5 中国药房 2026年第37卷第5期